ALX006 / Shanghai Ailux Biotechnology - LARVOL DELTA

ALX006, a PD-1/VEGF bispecific antibody with best-in-class potential demonstrates superior antitumor activity and favorable PK in preclinical models (AACR 2026) - "ALX006, a PD-1/VEGF bispecific antibody with best-in-class potential, demonstrates superior antitumor activity and favorable PK in preclinical models, supporting its potential as a therapeutic candidate for immuno-oncology applications."

Bispecific • Preclinical • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • IFNG • IL2 • PD-1